Top
Follow/Subscribe

Gary Null's latest shows and articles:

Categories
Books






Hear Gary Null every day at Noon (ET) on
Progressive Radio Network!

Or listen on the go with the brand new PRN mobile app! 
Click to download!

 

Like Gary Null on Facebook

Gary Null's Home-Based Business Opportunity

Special Offer: Gary Null's documentary "American Veterans: Discarded and Forgotten" DVD  is now available for $19.95! (regularly $40) Click here to order!
For more info. and to watch the Trailer for "American Veterans: Discarded and Forgotten", Click here!


Gary Null Films

Buy Today!:

CALL 877-627-5065

 

   

Check out our new website "The Vaccine Initiative" at www.vaccineinitiative.org - Educating your choice through Research, Articles, Video and Audio Interviews...  

 The latest from
Gary Null -
garynullfilms.com!
Now you can
instantly stream
Gary's films online. Each film costs 4.95, and you can view it straight from your computer!

Check out Big Green TV: Environmental Education for Kids!

ReturnReturn to Article

Recommend “Pamela MacLean and Karen Gullo” - Glaxo Attorney Says Abbott Tried to Stifle Competition With AIDS Medicine (Email)

This action will generate an email recommending this article to the recipient of your choice. Note that your email address and your recipient's email address are not logged by this system.

EmailEmail Article Link

The email sent will contain a link to this article, the article title, and an article excerpt (if available). For security reasons, your IP address will also be included in the sent email.

Article Excerpt:

Pamela MacLean and Karen Gullo

March 24, 2011

http://www.bloomberg.com/news/2011-03-24/glaxo-accuses-abbott-of-stifling-competition-in-aids-drug-price-increase.html

A GlaxoSmithKline Plc (GSK) lawyer told a federal court jury that Abbott Laboratories sought to stifle competition and maintain an illegal monopoly over HIV drugs when it quadrupled the price of its AIDS medicine Norvir in 2003.

Glaxo has argued at a trial in Oakland, California, that the price increase meant that other drugmakers couldn’t compete with Abbott’s Kaletra AIDS medicine, which includes Norvir, a boosting agent for other HIV drugs.

The London-based drugmaker claims it lost an estimated $570 million in profit on sales of its drug Lexiva, which uses Norvir, because it sold at half the rate the company expected. Glaxo is seeking damages of about three times its lost profits on Lexiva.


Article Link:
Your Name:
Your Email:
Recipient Email:
Message: